Yuil Biotech — Bioecon

简介

Yuil Biotech ((주)유일바이오텍) is an Euglena (microalgae) biotechnology company that develops functional ingredient materials for cosmetics and other industries, and also works on sustainable aviation fuel (SAF) feedstock using microbial production platforms. Its core technology is a proprietary microbial production process platform, “SN-TECH,” designed to improve mass-production efficiency and quality uniformity while reducing energy/time/cost burdens vs conventional sterilization-heavy microbial culture. Key branded materials include EX-GLEGEN™ (Euglena-derived exosomes for skincare; registered as a cosmetic ingredient). Company details: HQ in Cheongju, Chungcheongbuk-do (28161 충북 청주시 흥덕구 오송읍 오송생명2로 125, 511호) with additional sites in Seoul. Founding year is not stated in the provided results. Ownership/stock listing and funding are mentioned only indirectly: Socius PE holds ~67% via its portfolio company N-Cell (no public listing details provided). Scale (revenue, employees, capacity) is not provided. Partners/customers mentioned: S-OIL (MOU for Euglena-based SAF/BioAir oil R&D); and Korea University (with S-OIL and Yuil Biotech). Latest 2025–2026: launched vegan bio beauty brand “EUNEA” to commercialize its Euglena exosome platform (2025-12-17); obtained Marine Fisheries “NET” certification for next-gen mass microbial production technology (2026-01-17); and was selected as an “Outstanding Venture of the Month” in ), indicating it remains active.

Sources#

行业: 化妆品, 能源, 食品配料
主题: 微藻（螺旋藻、小球藻、裸藻）, 生物柴油、HVO 与可持续航空燃料
角色: 研究机构 — “…-do, Korea - Seoul branch/research center: 3rd floor, 269 Donggyo-ro, Mapo-gu, Seoul - Secondary research lab:…”

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

子公司: AirZeta (portfolio company of Socius PE)

新闻与状态 6

2026-08-26 Korea Venture Association honors three top startups in deep tech and biotech - CHOSUNBIZ
Youil Biotech develops and produces bio materials from a microbial production-platform called "SN-TECH," has expanded into functional cosmetics (EUNEA) and wellness products (EU:DAY), and is pursuing ongoing R&D to grow its functional biomaterials business …
2026-07-28 유일바이오텍, 연구개발형 벤처기업 재확인 - 서플
유일바이오텍이 벤처기업확인기관으로부터 연구개발유형 벤처기업으로 재확인받아, 자체 연구·개발 역량과 기술혁신성이 인정되었으며, 생물자원의 생산 한계를 기술로 보완하는 플랫폼을 기반으로 다양한 산업에 적용 가능한 생산 체계를 확장 중이라고 밝혔다.
2026-03-20 [This article was reported on Radar M, a paid media outlet specializing in the capital market in Mai.. - MK
Yuil Biotech has secured domestic microorganism-derived lipid production technology and produced energy-dense aviation oil (SAF) using its materials, meeting international standards (ASTM D7566) and demonstrating a pathway toward domestic, self-sufficient SAF …
2026-06-24 유일바이오텍, 4년 연속 'R&D혁신'대상 수상 - 머니투데이
Yuill Biotech (유일바이오텍) won the R&D Innovation Award for four consecutive years at the 2026 Korea Leading Companies Awards, highlighting its focus on Euglena-based sustainable aviation fuel (SAF) and broader biotech ventures in pharma, functional cosmetics, …
2026-08-26 From factory robots to AI scientists… 3 'Outstanding Ventures of the Month' Selected - 벤처스퀘어
Yuil Biotech was selected as the K-Scale-up Outstanding Venture of the Month, recognizing its scalable microbial production process platform (SN-TECH) that improves mass production efficiency, quality uniformity, and reduces energy, prep time, and costs in …
2026-05-28 유일바이오텍·성균관대, 유글레나 유래 엑소좀 혈뇌장벽 투과 가능성 확인 - 머니투데이
Yuil Biotech, in collaboration with Sungkyunkwan University, demonstrated in vitro that extracellular vesicles derived from Euglena can cross the blood-brain barrier with up to 8.8% efficiency and high RNA cargo loading, positioning their Euglena-based exosome …

关系网络：股东、合作伙伴、同类

股权与投资方 3

母公司	Socius PE
投资方	Socius PE
子公司	AirZeta

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录